The Effects of Sodium-Glucose Cotransporter-2 Inhibitors (SLGT-2i) on Cardiovascular and Renal Outcomes in Non-diabetic Patients: A Systematic Review

Globally, cardiovascular disease (CVD) and chronic kidney disease (CKD) are the leading causes of mortality. Despite medical advances, these illnesses are still underdiagnosed and undermanaged. Sodium-glucose cotransporter-2 inhibitors (SGLT-2i) have recently emerged as a potential class of medicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Giri Ravindran, Suganya, Kakarla, Meghana, Ausaja Gambo, Musa, Yousri Salama, Mustafa, Haidar Ismail, Nathalie, Tavalla, Pardis, Uppal, Pulkita, Mohammed, Shaza A, Rajashekar, Shriya, Hamid, Pousette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246463/
https://www.ncbi.nlm.nih.gov/pubmed/35800782
http://dx.doi.org/10.7759/cureus.25476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246463/
https://www.ncbi.nlm.nih.gov/pubmed/35800782
http://dx.doi.org/10.7759/cureus.25476

Ejemplares similares